15:23 IST
NSE
Results UpdateMankind Pharma Ltd MANKIND
Mankind Pharma Results Update
Mankind Pharma reported Q2 FY27 revenue of ₹4,338 Cr, up 17% YoY, and PAT of ₹716 Cr, up 38%. EBITDA margin improved 210 bps to 27.1%.
ALFA Filings
Every announcement, straight from the exchange
Every Mankind Pharma results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Mankind Pharma reported Q2 FY27 revenue of ₹4,338 Cr, up 17% YoY, and PAT of ₹716 Cr, up 38%. EBITDA margin improved 210 bps to 27.1%.
Mankind Pharma reported Q1 FY27 revenue of ₹4,031 crore, up 12.9% YoY. EBITDA grew 24.7% to ₹1,060 crore, with a margin of 26.3%.
Mankind Pharma reported FY26 revenue of ₹14,278 Crore, up 17% YoY. Q4FY26 adjusted EBITDA margins reached 27.1%, driven by strong domestic chronic and OTC growth.